Literature DB >> 31661433

Role of Nanomedicine in Redox Mediated Healing at Molecular Level.

Aniruddha Adhikari1, Susmita Mondal1, Soumendra Darbar2, Samir Kumar Pal1.   

Abstract

Nanomedicine, the offspring born from the marriage of nanotechnology and medicine, has already brought momentous advances in the fight against a plethora of unmet diseases from cardiovascular and neurodegenerative to diabetes and cancer. Here, we review a conceptual framework that will provide a basic understanding about the molecular mechanism of action of a therapeutic nanomaterial inside biological milieu. In this review, we highlight how the catalytic nature of a transition metal oxide nanomaterial influences the cellular redox homeostasis, supports the cellular antioxidant defence system and reactivates the reactive oxygen species (ROS) mediated signalling to perform normal cell functions like cell cycle, differentiation, apoptosis, inflammation, toxicity, and protein interactions. With numerous examples, we describe the redox modulatory nature of d-block metal oxide nanomaterials and their biomimetic nanozyme activities to protect the mitochondria, the cellular redox mediator which prevents an organism from various diseases. This knowledge will be useful to design new nanomaterials capable of intracellular redox modulation, which in turn can be effective therapeutic agents for treatment of various unmet diseases that are beyond the ability of modern synthetic medicine.

Entities:  

Keywords:  Cellular redox homeostasis; Nanotherapy; Nanozyme; Reactive oxygen species; Surface functionalization

Mesh:

Substances:

Year:  2019        PMID: 31661433     DOI: 10.1515/bmc-2019-0019

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  6 in total

1.  Chemoprevention of bilirubin encephalopathy with a nanoceutical agent.

Authors:  Aniruddha Adhikari; Vinod K Bhutani; Susmita Mondal; Monojit Das; Soumendra Darbar; Ria Ghosh; Nabarun Polley; Anjan Kumar Das; Siddhartha Sankar Bhattacharya; Debasish Pal; Asim Kumar Mallick; Samir Kumar Pal
Journal:  Pediatr Res       Date:  2022-07-06       Impact factor: 3.756

2.  Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice.

Authors:  Aniruddha Adhikari; Susmita Mondal; Tanima Chatterjee; Monojit Das; Pritam Biswas; Ria Ghosh; Soumendra Darbar; Hussain Alessa; Jalal T Althakafy; Ali Sayqal; Saleh A Ahmed; Anjan Kumar Das; Maitree Bhattacharyya; Samir Kumar Pal
Journal:  Commun Biol       Date:  2021-08-26

3.  Implementation of surface functionalization of MnS nanoparticles for achieving novel optical properties and improving therapeutic potential.

Authors:  Arpan Bera; Md Nur Hasan; Nivedita Pan; Ria Ghosh; Reem A Alsantali; Hatem M Altass; Rami J Obaid; Saleh A Ahmed; Samir Kumar Pal
Journal:  RSC Adv       Date:  2022-07-19       Impact factor: 4.036

Review 4.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 5.  Nanotechnology Toolkit for Combating COVID-19 and Beyond.

Authors:  Giredhar Muthiah; Ankita Sarkar; Shounak Roy; Prem Singh; Praveen Kumar; Keshav Bhardwaj; Amit Jaiswal
Journal:  ChemNanoMat       Date:  2022-03-10       Impact factor: 3.820

Review 6.  Reactive oxygen species (ROS) as pleiotropic physiological signalling agents.

Authors:  Helmut Sies; Dean P Jones
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-30       Impact factor: 113.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.